Edition:
India

Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

86.68USD
19 Jan 2018
Change (% chg)

$-0.58 (-0.66%)
Prev Close
$87.26
Open
$87.58
Day's High
$87.90
Day's Low
$86.04
Volume
2,078,915
Avg. Vol
1,466,026
52-wk High
$89.71
52-wk Low
$73.59

Chart for

About

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group,... (more)

Overall

Beta: 1.00
Market Cap(Mil.): $108,109.90
Shares Outstanding(Mil.): 1,354.59
Dividend: 0.46
Yield (%): 2.31

Financials

BRIEF-Medtronic Receives FDA Clearance For Riptide Aspiration System

* MEDTRONIC RECEIVES FDA CLEARANCE FOR RIPTIDE(TM) ASPIRATION SYSTEM

16 Jan 2018

China cracks down on foreign companies calling Taiwan, other regions countries

SHANGHAI China's aviation authority on Friday demanded an apology from Delta Air Lines for listing Taiwan and Tibet as countries on its website, while another government agency took aim at Inditex-owned fashion brand Zara and medical device maker Medtronic Plc for similar issues.

12 Jan 2018

UPDATE 2-China cracks down on foreign companies calling Taiwan, other regions countries

* Highlights Chinese sensitivities over territorial sovereignty (Changes headline)

12 Jan 2018

BRIEF-FDA Approves Innovative Clinician Programmer For The Medtronic Synchromed II Intrathecal Drug Delivery System

* FDA APPROVES INNOVATIVE CLINICIAN PROGRAMMER FOR THE MEDTRONIC SYNCHROMED II INTRATHECAL DRUG DELIVERY SYSTEM FOR CHRONIC PAIN AND SEVERE SPASTICITY Source text for Eikon: Further company coverage:

10 Jan 2018

Medtronic unveils restructuring plan

Medtronic Plc on Monday unveiled a restructuring plan that it expects will help it save $500 million to $700 million annually over the next five years.

09 Jan 2018

Medtronic unveils restructuring plan

Jan 8 Medtronic Plc on Monday unveiled a restructuring plan that it expects will help it save $500 million to $700 million annually over the next five years.

09 Jan 2018

BRIEF-Bob White Named President Of Medtronic's Minimally Invasive Therapies Group

* BOB WHITE NAMED EXECUTIVE VICE PRESIDENT AND PRESIDENT OF MEDTRONIC'S MINIMALLY INVASIVE THERAPIES GROUP; CHRIS LEE TO ASSUME LEADERSHIP OF MEDTRONIC'S ASIA PACIFIC REGION Source text for Eikon: Further company coverage:

19 Dec 2017

Medtronic settles states' probe into Infuse marketing for $12 million

BOSTON Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday.

14 Dec 2017

UPDATE 2-Medtronic settles states' probe into Infuse marketing for $12 mln

BOSTON, Dec 13 Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday.

14 Dec 2017

Medtronic settles states' probe into Infuse marketing for $12 mln

BOSTON, Dec 13 Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday.

13 Dec 2017

Earnings vs. Estimates